Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon
† Study has passed its completion date and status has not been verified in more than two years.